Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma

Virchows Archiv

Volumn 447, Issue 4, 2005, Pages 695-700

  Riva, Cristina ^a   Dainese, Emanuele ^a   Caprara, Giacomo ^b   Rocca, Paolo Cossu ^c   Massarelli, Giovanni ^c   Tot, Tibor ^d   Capella, Carlo ^a   Eusebi, Vincenzo ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d FALUN HOSPITAL   (Sweden)

Author keywords

Androgen receptors; Breast carcinoma; Lobular carcinoma

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 27644442226     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0003-6     Document Type: Article

References (41)

1. Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ (2003) Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations. Am J Clin Pathol 120:725-731
2. Barnes DM, Hanby AM (2001) Oestrogen and progesterone receptors in breast cancer: past, present and future. Histopathology 38:271-274
3. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G (1996) Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 88:291-296
4. Berstein L, Ross RK (1993) Endogenous hormones and breast cancer risk. Epidemiol Rev 15:48-65
5. Birrell SN, Hall RE, Tilley WD (1998) Role of the androgen receptor in human breast cancer. J Mammary Biol Neoplasia 3:95-103
6. Brinkmann AO, Blok LJ, de Ruiter PE, Doesburg P, Steketee K, Berrevoets CA, Trapman J (1999) Mechanism of androgen receptor activation and function. J Steroid Biochem Mol Biol 69:307-313
7. Brys M, Wojcik M, Romanowicz-Makowska H, Krajewska WM (2002) Androgen receptor status in female breast cancer: RT-PCR and Western blot studies. J Cancer Res Clin Oncol 128:85-90
8. Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR (1999) Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann Intern Med 130:270-277
9. Collett K, Maehle BO, Skjarven R (1996) Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patients with breast cancer. Breast 5:123-126
10. Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R (2002) Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer 95:2455-2464
11. Ellis LM, Wittliff L, Bryant MS (1989) Correlation of estrogen, progesterone and androgen receptors in breast cancer. Am J Surg 157:577-581
12. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410
13. Eusebi V, Magalhaes F, Azzopardi JG (1992) Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Human Pathol 23:655-662
14. Foekens JA, Portensen H, Van Putten WLJ (1989) Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassay in human breast tumor cytosols. Cancer Res 49:5823-5828
15. Gatalica Z (1997) Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract 193:753-758
16. Hackenberg R, Hawighorst T, Filmer A, Nia AH, Schulz KD (1993) Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via androgen receptor. Breast Cancer Res Treat 25:217-224
17. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90:1292-1299
18. Hawkins RA, Roberts MM, Forrest AP (1980) Oestrogen receptors and breast cancer: current status. Br J Surg 67:162-165
19. Isola JJ (1993) Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol 170:31-35
20. Kimura N, Mizokami A, Oonuma T, Sasano H, Natura H (1993) Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissue. J Histochem Cytochem 41:671-678
21. Kuenen-Boumeester V, Vanderkwast TH, Van Putten WLJ, Claassen C, Vanooijen B, Henzenlogmans SC (1992) Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. Int J Cancer 52:581-584
22. Lea OA, Kvinnsland S, Thorsen T (1989) Improved measurement of androgen receptors in human breast cancer. Cancer Res 49:7162-7167
23. Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR (2003) Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 289:3254-3263
24. Li CI, Weiss NS, Stanford JL, Daling JR (2000) Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 88:2570-2577
25. Lillie E, Bernstein L, Ursin G (2003) The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer. Breast Cancer Res 5:164-173
26. Lippman M, Bolan G, Huff K (1976) The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4610-4618
27. Micheli A, Muti P, Secreto G, Krogh V, Meneghini E, Venturelli E, Sieri S, Pala V, Berrino F (2004) Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 112:312-318
28. Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF, Weybora W, Ratschek M, Tavassoli FA, Denk H (2003) Androgen receptors frequently are expressed in breast carcinomas. Cancer 98:703-711
29. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N, Waldman FM (1997) Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 74:513-517
30. Pichon MF, Broet P, Magdelenat H, Delarue JC, Spyratos F, Basuyan JP, Saez S, Rallet A, Courriere P, Millon R, Asselain B (1996) Prognostic value of steroid receptors after long term follow-up of 2257 operable breast cancers. Br J Cancer 73:1545-1551
31. Selim A, El-Ayat G, Wells A (2002) Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors. J Clin Pathol 55:14-16
32. Soreide JA, Lea OA, Varhaug JE, Skarstein A, Kvinnsland S (1992) Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlation to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Eur J Surg Oncol 18:112-118
33. Tavassoli FA, Devilee P (eds) (2003) Pathology and genetics of tumours of the breast and female genital organs. World Health Organization Classification of Tumors. IARC Press, Lyon
34. Teulings FA, van Gilse HA, Henkelman MS, Portensen H, Alexieva-Figusch J (1980) Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer. Cancer Res 40:2557-2561
35. Thorpe SM (1988) Estrogen and progesterone receptor determinations in breast cancer. Acta Oncol 27:1-18
36. Thorpe SM, Rose C (1986) Oestrogen and progesterone receptor determination in breast cancer; technology and biology. Cancer Surv 5:505-525
37. TNM Classification of Malignant Tumours, Sixth Edition (2002)
38. Verkooijen HM, Fioretta G, Vlastos G, Morabia A, Schubert H, Sappino AP, Pelte MF, Schafer P, Kurtz J, Bouchardy C (2003) Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 104:778-781
39. Wenger CR, Beardslee S, Owens MA, Pounds G, Oldaker T, Vendely P, Pandian MR, Harrington D, Clark GM, Mc Guire WL (1993) DNA-ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 28:9-26
40. Wittliff JL (1984) Steroid-hormone receptors in breast cancer. Cancer 53:630-643
41. Zumoff B, Levin J, Rosenfeld RS, Markham M, Strain GW, Fukushima DK (1981) Abnormal 24-h mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer. Cancer Res 41:3360-3363